Table 1. Baseline Characteristics by Treatment Group.
| Overall (n=307) |
Drug Alone (n=153) |
Drug Plus Behavior (n=154) |
|
|---|---|---|---|
| Demographic Characteristics | |||
| Age - Mean (SD) | 56.9 (13.9) | 58 (13.5) | 55.8 (14.2) |
| Race/ethnic group - N (%) | |||
| Hispanic | 30 (10) | 17 (11) | 13 (8) |
| Non-Hispanic White | 190 (62) | 85 (56) | 105 (69) |
| Non-Hispanic Black | 57 (19) | 35 (23) | 22 (14) |
| Non-Hispanic other | 28 (9) | 15 (10) | 13 (8) |
| Education level - N (%) | |||
| <= High school | 71 (23) | 31 (20) | 40 (26) |
| >High school | 236 (77) | 122 (80) | 114 (74) |
| Income - N (%) | |||
| <$20,000 | 70 (25) | 38 (27) | 32 (23) |
| $20,000-49,999 | 104 (37) | 38 (27) | 66 (46) |
| $50,000-79,999 | 59 (21) | 38 (27) | 21 (15) |
| $80,000+ | 51 (18) | 28 (20) | 23 (16) |
| Occupational Score - Mean (SD) | 60.7 (24) | 64 (24.3) | 57.5 (23.3) |
| Baseline Incontinence Characteristics | |||
| MESA stress score - Mean (SD) | 10.6 (6.2) | 10.3 (6) | 11 (6.3) |
| MESA urge score - Mean (SD) | 11.1 (3.4) | 10.8 (3.2) | 11.3 (3.5) |
| Number of Incontinence Episodes per week on Bladder Diary at Baseline -Mean (SD) | 3.7 (2.4) | 3.7 (2.4) | 3.7 (2.5) |
| IIQ scores - Mean (SD) | 153.6 (99.5) | 153 (99.9) | 154.2 (99.4) |
| OAB-q score - Mean (SD) | 61.7 (24.1) | 61.5 (24.3) | 62 (24) |
| Duration of Incontinence - Mean (SD) | 9.5 (9.9) | 9.1 (10.3) | 9.8 (9.5) |
| Prior treatment/surgery for incontinence - N (%) | |||
| Yes | 123 (40) | 57 (37) | 66 (43) |
| No | 184 (60) | 96 (63) | 88 (57) |
| Medical History and Physical | |||
| Self assessment of overall health (question B1) - N (%) | |||
| Excellent | 37 (12) | 17 (11) | 20 (13) |
| Very good | 104 (34) | 52 (34) | 52 (34) |
| Good | 108 (35) | 53 (35) | 55 (36) |
| Faira | 50 (16) | 27 (18) | 23 (15) |
| Poora | 7 (2) | 3 (2) | 4 (3) |
| Fluid Intake (oz) - Mean (SD) | 65.6 (28.2) | 67.3 (27.9) | 64 (28.5) |
| Current estrogen use - N (%) | |||
| Post-menopausal on HRT | 54 (18) | 27 (19) | 27 (17) |
| Post-menopausal not on HRT | 151 (49) | 79 (51) | 72 (47) |
| Pre-menopausal | 102 (33) | 47 (31) | 55 (36) |
| Diabetes - N (%) | |||
| Yes | 39 (13) | 20 (13) | 19 (12) |
| No | 268 (87) | 133 (87) | 135 (83) |
| Body mass index - Mean (SD) | 32.7 (8.6) | 32.3 (7.6) | 33.2 (9.5) |
| POP-Q - N (%) | |||
| 0/I | 193 (63) | 93 (61) | 100 (65) |
| II | 103 (34) | 52 (34) | 51 (33) |
| III/IV | 10 (3) | 8 (5) | 2 (1) |
| POPQ_AA - Mean (SD) | -1.9 (1.1) | -1.8 (1.1) | -2.0 (1.0) |
| POPQ_BA - Mean (SD) | -1.9 (1.1) | -1.8 (1.2) | -2.0 (1.0) |
| POPQ_Bp - Mean (SD) | -2.2 (1.0) | -2.2 (1.1) | -2.2(1.0) |
| POPQ_C – Mean (SD) | -7.0 (3.0) | -6.7 (3.4) | -7.2 (2.5) |
| Pelvic floor muscle strength (Brink's score) - Mean (SD) | 8.9 (1.7) | 8.9 (1.7) | 8.9 (1.7) |
| Fecal Incontinence | |||
| Yes | 56 (18) | 30 (20) | 26 (17) |
| No | 251 (82) | 123 (80) | 128 (83) |
| SF-12 | |||
| PCS12 - Mean (SD) | 45 (11.3) | 44.5 (11.6) | 45.5 (11.1) |
| MCS12 – Mean (SD) | 48.3 (10.6) | 48.9 (10.4) | 47.7 (10.8) |
| HUI2 - Overall - Mean (SD) | 0.8 (0.2) | 0.8 (0.1) | 0.8 (0.2) |
a
The “fair” and “poor” groups were combined for analysis due to the small sample size in the “poor” group.